MogensenCE. Predictors of clinical nephropathy in IDDM patients. Alternatives to microalbuminuria?Diabetes1990; 39: 761–7.
2.
RoweDJFAnthonyFPolakAShawKWardCDWattsGF. Retinol binding protein as a small molecular weight marker of renal tubular function in diabetes mellitus. Ann Clin Biochem1987; 24: 477–82.
3.
WattsGFVlitosMAJMorrisRWPriceRG. Urinary N-acetyl-β-D-glucosaminidase excretion in insulin-dependent diabetes mellitus: Relation to microalbuminuria, retinopathy and glycaemic control. Diabete Metab1988; 14: 653–8.
4.
PowrieJKWattsGFInghamJNTaubNATalmudPJShawKM. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. BMJ1994; 309: 1608–12.
5.
WattsGFHarrisRShawKM. The determinants of early nephropathy in insulin-dependent diabetes mellitus: A prospective study based on the urinary excretion of albumin. Q J Med1991; 79: 365–78.
6.
WattsGFBennetJERoweDJFMorrisRWGatlingWShawKMAssessment of immunochemical methods for determining low concentrations of albumin in urine. Clin Chem1986; 32: 1544–8.